PT3 SUBSTAGING IS A PROGNOSTIC INDICATOR IN LYMPH NODE NEGATIVE UROTHELIAL CARCINOMA OF THE BLADDER

被引：0

作者：

Tilki, D. ^{[1
]}

Novara, G. ^{[2
]}

Ficarra, V ^{[2
]}

Seitz, M. ^{[1
]}

Kassouf, W. ^{[3
]}

Fradet, Y. ^{[4
]}

Skinner, E. ^{[5
]}

Stief, C. G. ^{[1
]}

Reich, O. ^{[6
]}

Shariat, S. F. ^{[7
]}

机构：

[1] Univ Munich, Dept Urol, Munich, Germany

[2] Univ Padua, Dept Urol, Padua, Italy

[3] McGill Univ, Ctr Hlth, Dept Urol, Montreal, PQ, Canada

[4] Univ Laval, Dept Urol, Quebec City, PQ, Canada

[5] Univ So Calif, Dept Urol, Los Angeles, CA USA

[6] Klinikum Harlaching, Dept Urol, Munich, Germany

[7] Weill Cornell Med Coll, Dept Urol, New York, NY USA

来源：

EUROPEAN UROLOGY SUPPLEMENTS | 2011年 / 10卷 / 02期

关键词：

D O I：

10.1016/S1569-9056(11)60246-7

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

下载

页码：99 / 99

页数：1

共 50 条

[21] Prognostic utility of the 1997 TNM bladder cancer substaging classification system for PT2 and PT3 disease: Results from the bladder cancer research consortium (BCRC)
不详
EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (03) : 35 - 35
[22] PT2 SUBSTAGING IN UROTHELIAL CARCINOMA OF THE BLADDER: DEEP MUSCLE INVASION IS ASSOCIATED WITH WORSE OUTCOME
Tilki, Derya
Reich, Oliver
Karakiewicz, Pierre
Novara, Giacomo
Kassouf, Wassim
Fradet, Yves
Ficarra, Vincenzo
Seitz, Michael
Skinner, Eila
Svatek, Robert
Lotan, Yair
Sagalowsky, Arthur
Stief, Christian
Shariat, Shahrokh
JOURNAL OF UROLOGY, 2011, 185 (04): : E757 - E757
[23] Prognostic Significance of Measured Depth of Invasion of Urothelial Carcinoma of the Bladder Compared to the 2010 American Joint Committee on Cancer pT2 and pT3 Classifications
Zarei, Shabnam
Frank, Igor
Boorjian, Stephen A.
Thompson, R. Houston
Kim, Simon
Weight, Christopher
Tarrell, Robert
Thapa, Prabin
Cheville, John C.
JOURNAL OF UROLOGY, 2012, 188 (05): : 1706 - 1711
[24] Is pT3 urothelial carcinoma of the renal pelvis a homogeneous disease entity? Proposal for a new subcategory of the pT3 classification
Sassa, Naoto
Tsuzuki, Toyonori
Fukatsu, Akitoshi
Majima, Tsuyoshi
Kimura, Tohoru
Nishikimi, Toshinori
Yoshino, Yasushi
Hattori, Ryohei
Gotoh, Momokazu
HISTOPATHOLOGY, 2012, 61 (04) : 620 - 628
[25] The role of adjuvant chemotherapy in patients with locally advanced (pT3, pT4a) and/or lymph node–positive bladder cancer
Berkan Reşorlu
Kadir Türkölmez
Gül Ergün
Sümer Baltacı
Çağatay Göğüş
Yaşar Bedük
International Urology and Nephrology, 2010, 42 : 959 - 964
[26] Advances in the evaluation and management of lymph node involvement in urothelial carcinoma of the bladder
Siddiqui, Mohummad Minhaj
Feldman, Adam S.
EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (12) : 1855 - 1859
[27] Sentinel lymph node biopsy in urothelial urinary bladder cell carcinoma
Sherif, A.
ANNALS OF SURGICAL ONCOLOGY, 2008, 15 : 23 - 23
[28] Metastasis of bladder urothelial carcinoma to cervical lymph node: A case report
Wang, Zengjun
Lv, Qiang
Li, Pengchao
Su, Shifeng
Huo, Yibo
Zhao, Kai
Xu, Aiming
Wei, Chen
Shao, Pengfei
Qin, Chao
Liu, Yiyang
INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 : 46 - 46
[29] Molecular Lymph Node Staging in Bladder Urothelial Carcinoma: Impact on Survival
Marin-Aguilera, Mercedes
Mengual, Lourdes
Burset, Moises
Oliver, Artur
Ars, Elisabet
Ribal, Maria Jose
Colomer, Dolors
Mellado, Begona
Villavicencio, Humberto
Algaba, Ferran
Alcaraz, Antonio
EUROPEAN UROLOGY, 2008, 54 (06) : 1363 - 1372
[30] Surgical intervention in patients with urothelial carcinoma of the bladder and lymph node metastasis
Abufaraj, Mohammad
Al-Ani, Abdallah
AlQudah, Alex
Shariat, Shahrokh F.
CURRENT OPINION IN UROLOGY, 2021, 31 (03) : 220 - 225

← 1 2 3 4 5 →